期刊文献+

茶多酚抑制大鼠血管平滑肌细胞增殖及相关机制研究

To Study the Effects of Tea Polyphenols Inhibit the Proliferation of Rat Vascular Smooth Muscle Cells and the Related Mechanism
下载PDF
导出
摘要 目的:研究晚期糖基化产物(AGEs)对大鼠血管平滑肌细胞A7R5增殖的影响及相关机制。方法:用AGEs处理A7R5细胞,相同条件BSA处理为对照组,Western blotting检测RAGE蛋白表达的变化,MTT比色法测定细胞活性。结果:AGEs处理A7R5细胞后,AGEs受体RAGE及细胞增殖水平均明显升高,但与EGCG共孵育能显著抑制AGEs诱导的RAGE表达增加及细胞增殖水平。结论:EGCG能够抑制AGEs诱导的大鼠血管平滑肌细胞增殖水平,这可能与EGCG抑制AGEs受体RAGE的表达相关。 Objective To investigate the effect of advanced glyeation end product - induced proliferation of vascular smooth muscle cells (VSMCs) A7R5 and explore the mechanism. Methods After cultured VSMCs were treated with advanced glycation end products (AGEs) or BSA,RAGE expression was detected by Western blot; cell variability was quantified by MTr assay. Results After cultured VSMCs were treated with AGEs,the level of protein RAGE and the proliferation rate of VSMCs was up -regulated. However,the RAGE ex- press and the proliferation rate of VSMCs was decreased co - incubation with EGCG in AGEs - treated group. Conclusion EGCG can inhib- it AGE~ -induced proliferation of vascular smooth muscle cells (VSMCs). It may relate to the AGEs -induced RAGE low expression.
出处 《吉林医学》 CAS 2013年第26期5315-5317,共3页 Jilin Medical Journal
关键词 茶多酚 晚期糖基化产物 RAGE 大鼠血管平滑肌细胞 EGCG Advanced glycation end products The receptor for advanced glycation end products Rat vascular smooth muscle cells
  • 相关文献

参考文献12

  • 1Bierhaus A, Hofmann MA and Ziegler R, et al. AGEs and their interaction with AGE - receptors in vascular disease and dia- betes meUitus. I. The AGE concept [ J ]. Cardiovasc Res, 1998, 37(3) : 586.
  • 2Rojas A and Morales MA. Advanced glycation and endothe- lial functions: A link towards vascular complications in diabetes [J]. Life Sciences,2004,76(7) : 715.
  • 3Garay - Sevilla ME, Regalado JC and Malacara JM, et al. Advanced glycosylation end products in skin, serum, saliva and u- fine and its association with complications of patients with Type 2 diabetes mellitus [ J ]. Journal of Endocrinological Investigation, 2005,28(3) : 223.
  • 4Hou FF, Chertow GM and Kay J, et al. Interaction between beta 2 - microglobulin and advanced glycation end products in the development of dialysis related amyloidosis[ J]. Kidney Int, 1997, 51 (5) : 1514.
  • 5张力,付瑶,牟少静,李艳春.2型糖尿病外周血管病变与其他糖尿病并发症相关性的研究[J].吉林医学,2010,31(28):4872-4873. 被引量:7
  • 6Goldin A, Beckman JA and Schmidt AM, et al. Advanced glycation end products: sparking the development of diabetic vas- cular injury[ J ]. Circulation ,2006,114 (6) : 597.
  • 7Lander HM, Tanras JM and Ogiste JS, et al. Activation of the receptor for advanced glycation end products triggers a p21 (ras) - dependent mitogen - activated protein kinase pathway reg- ulated by oxidant stress[ J ]. J Biol Chem, 1997,272(28) : 17810.
  • 8Huttunen H J, Fages C and Rauvala H. Receptor for ad- vanced glycation end products (RAGE) - mediated neurite out- growth and activation of NF - kappaB require the cytoplasmic do- main of the receptor but different downstream signaling pathways [J]. J Biol Chem,1999,274(28) : 19919.
  • 9Basta G, Lazzerini G and Del Tureo S,et al. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell ad- hesion molecule- 1 induction by advanced glycation end products [J]. Arterioscler Thromb Vasc Biol,2005,25(7) : 1401 - 1407.
  • 10Xu B, Chibber R and Ruggiero D,et al. Impairment of vas- cular endothelial nitric oxide synthase activity by advanced glyca- tion end products[J]. FASEB J,2003,17(10) : 1289.

二级参考文献5

  • 1Greenland P,Abrams J,Aurigemma GP.Beyond secondary prevention:identifying the high-risk patient for primary prevention:noninvasive tests of atherosclerotic burden:writing group Ⅲ[J].Circulation,2000,101:E16.
  • 2American Diabetes Association.Standards of medical care in diabetes-2007[J].Diabetes Care,2007,30(suppl):12.
  • 3Chmidt AM.Cellular receptors for advanced glycation end products[J].Arterioscler Thromb,1994,14(15):1521.
  • 4Radkin P.Risk factors for the development of complications of diabetic complications[J].J Diabetes Comp,1994,8(2):195.
  • 5Tsai SC,Burnakis TG.Aldose reductase inhibitors:an update[J].Ann Pharmacotherapy,1993,27(7):751.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部